Vera Therapeutics, Inc.
6 clinical trials · Sponsor
◉ Watch Vera Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Atacicept in Multiple Glomerular Diseases (NCT06983028) | Vera Therapeutics, Inc. | 2025-07-07 |
| Monthly Dosing of Atacicept in IgAN (NCT07020923) | Vera Therapeutics, Inc. | 2025-05-29 |
| A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept (NCT06674577) | Vera Therapeutics, Inc. | 2024-12-01 |
| Atacicept in Subjects With IgA Nephropathy (NCT04716231) | Vera Therapeutics, Inc. | 2023-06-29 |
| Atacicept in Subjects With Active Lupus Nephritis (COMPASS) (NCT05609812) | Vera Therapeutics, Inc. | 2022-11-02 |
| A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients (NCT04294472) | Vera Therapeutics, Inc. | 2020-08-05 |
Track Vera Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.